Traditional diagnoses of major depressive disorder (MDD) suggested that the presence or absence of stress prior to onset results in either 'reactive' or 'endogenous' subtypes of the disorder, respectively. Several lines of research suggest that the biological underpinnings of 'reactive' or 'endogenous' subtypes may also differ, resulting in differential response to treatment. We investigated this hypothesis by comparing the gene-expression profiles of three animal models of 'reactive' and 'endogenous' depression. We then translated these findings to clinical samples using a human post-mortem mRNA study
Background: The Flinders model is a validated genetic rat model of depression that exhibits a number...
Background: The Flinders model is a validated genetic rat model of depression that exhibits a number...
Depression is a complex, heterogeneous disorder and a leading contributor to the global burden of di...
BACKGROUND: Traditional diagnoses of major depressive disorder (MDD) suggested that the presence or...
The Genome-Based Therapeutic Drugs for Depression study was funded by a European Commission Framewor...
endogenous and reactive depression subtypes revisited: integrative animal and human studies implicat...
Response to antidepressant treatment in major depressive disorder (MDD) cannot be predicted currentl...
The etiology of depression is still poorly understood, but two major causative hypotheses have been ...
Objective: Major depressive disorder is a heterogeneous illness with a mostly uncharacterized pathol...
Despite moderate heritability estimates, progress in uncovering the molecular substrate underpinning...
National audienceMajor depressive disorder (MDD) is a leading cause of disability worldwide and alte...
The search for genetic variants underlying major depressive disorder (MDD) has not yet provided firm...
Treatment-resistant depression (TRD) occurs in ~30% of patients with major depressive disorder (MDD)...
The disease signature of major depressive disorder is distributed across multiple physical scales an...
Background: The Flinders model is a validated genetic rat model of depression that exhibits a number...
Background: The Flinders model is a validated genetic rat model of depression that exhibits a number...
Depression is a complex, heterogeneous disorder and a leading contributor to the global burden of di...
BACKGROUND: Traditional diagnoses of major depressive disorder (MDD) suggested that the presence or...
The Genome-Based Therapeutic Drugs for Depression study was funded by a European Commission Framewor...
endogenous and reactive depression subtypes revisited: integrative animal and human studies implicat...
Response to antidepressant treatment in major depressive disorder (MDD) cannot be predicted currentl...
The etiology of depression is still poorly understood, but two major causative hypotheses have been ...
Objective: Major depressive disorder is a heterogeneous illness with a mostly uncharacterized pathol...
Despite moderate heritability estimates, progress in uncovering the molecular substrate underpinning...
National audienceMajor depressive disorder (MDD) is a leading cause of disability worldwide and alte...
The search for genetic variants underlying major depressive disorder (MDD) has not yet provided firm...
Treatment-resistant depression (TRD) occurs in ~30% of patients with major depressive disorder (MDD)...
The disease signature of major depressive disorder is distributed across multiple physical scales an...
Background: The Flinders model is a validated genetic rat model of depression that exhibits a number...
Background: The Flinders model is a validated genetic rat model of depression that exhibits a number...
Depression is a complex, heterogeneous disorder and a leading contributor to the global burden of di...